4th Quarter - Report
PORTERFIELD, FETTIG & SEARS, LLC for ASTELLAS PHARMA US, INC.
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing.
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has advocated and listed herein.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEREMY RABINOVITZ | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.